VEFAİ KARA, M. Et Al. 2013. Is CYP2C9 polymorphism associated with colorectal cancer risk?. 48th Congress of the European Societies of Toxicology , (Sweden), 3.

VEFAİ KARA, M., ALPERTUNGA, B., & ÖZHAN, G., (2013). Is CYP2C9 polymorphism associated with colorectal cancer risk? . 48th Congress of the European Societies of Toxicology (pp.3). , Sweden

VEFAİ KARA, Mehtap, Büket ALPERTUNGA, And Gül ÖZHAN. "Is CYP2C9 polymorphism associated with colorectal cancer risk?," 48th Congress of the European Societies of Toxicology, Sweden, 2013

VEFAİ KARA, Mehtap Et Al. "Is CYP2C9 polymorphism associated with colorectal cancer risk?." 48th Congress of the European Societies of Toxicology , Sweden, pp.3, 2013

VEFAİ KARA, M. ALPERTUNGA, B. And ÖZHAN, G. (2013) . "Is CYP2C9 polymorphism associated with colorectal cancer risk?." 48th Congress of the European Societies of Toxicology , Sweden, p.3.

@conferencepaper{conferencepaper, author={Mehtap KARA Et Al. }, title={Is CYP2C9 polymorphism associated with colorectal cancer risk?}, congress name={48th Congress of the European Societies of Toxicology}, city={}, country={Sweden}, year={2013}, pages={3} }